Get the Stockscreener App
1.38
4.83%
-0.07
After Hours:
1.38
Allarity Therapeutics Inc stock is traded at $1.38, with a volume of 282.90K.
It is down -4.83% in the last 24 hours and down -10.97% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.45
Open:
$1.43
24h Volume:
282.90K
Relative Volume:
0.04
Market Cap:
$20.18M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.0067
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
+2.99%
1M Performance:
-10.97%
6M Performance:
+24.32%
1Y Performance:
+0.00%
1-Day Range:
$1.33
$1.43
1-Week Range:
$1.33
$1.49
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.38 | 21.06M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
How Allarity Therapeutics Inc. stock reacts to oil pricesEarnings Performance Report & Free Community Supported Trade Ideas - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
How to build a dashboard for Allarity Therapeutics Inc. stockEntry Point & Step-by-Step Swing Trade Plans - newser.com
Real time breakdown of Allarity Therapeutics Inc. stock performanceMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Why hedge funds are buying Allarity Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
Can momentum traders help lift Allarity Therapeutics Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsOil Prices & AI Driven Price Forecasts - newser.com
Using economic indicators to assess Allarity Therapeutics Inc. potential2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
What analyst consensus says on Allarity Therapeutics Inc. stockQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Can Allarity Therapeutics Inc. stock deliver surprise earnings beatDividend Hike & Daily Volume Surge Trade Alerts - newser.com
Why Allarity Therapeutics Inc. stock is favored by top institutionsMarket Activity Report & Low Risk Entry Point Guides - newser.com
Risk adjusted return profile for Allarity Therapeutics Inc. analyzed - newser.com
Is Allarity Therapeutics Inc. stock affected by interest rate hikesPortfolio Value Report & Low Drawdown Investment Strategies - newser.com
Using data filters to optimize entry into Allarity Therapeutics Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Real time pattern detection on Allarity Therapeutics Inc. stockMarket Performance Report & Weekly Return Optimization Plans - newser.com
Chart based exit strategy for Allarity Therapeutics Inc.July 2025 Snapshot & Safe Capital Allocation Plans - newser.com
Will Allarity Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Earnings & Smart Investment Allocation Insights - newser.com
Using AI based signals to follow Allarity Therapeutics Inc.Earnings Risk Report & Step-by-Step Trade Execution Guides - newser.com
Applying sector rotation models to Allarity Therapeutics Inc.Analyst Downgrade & Real-Time Buy Signal Alerts - newser.com
What earnings revisions data tells us about Allarity Therapeutics Inc.July 2025 Patterns & Verified Technical Signals - newser.com
Published on: 2025-11-02 03:15:08 - newser.com
Published on: 2025-11-01 05:12:49 - newser.com
Is it too late to sell Allarity Therapeutics Inc.July 2025 Review & Entry Point Confirmation Signals - newser.com
How Allarity Therapeutics Inc. stock performs in weak economy2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):